Bipolar Disorders

Volume 13, Issue 1 p. 52-58

Markers of gluten sensitivity and celiac disease in bipolar disorder

Faith Dickerson,

Faith Dickerson

The Stanley Research Program at Sheppard Pratt, Baltimore, MD

Search for more papers by this author

Cassie Stallings,

Cassie Stallings

The Stanley Research Program at Sheppard Pratt, Baltimore, MD

Search for more papers by this author

Andrea Origoni,

Andrea Origoni

The Stanley Research Program at Sheppard Pratt, Baltimore, MD

Search for more papers by this author

Crystal Vaughan,

Crystal Vaughan

The Stanley Research Program at Sheppard Pratt, Baltimore, MD

Search for more papers by this author

Sunil Khushalani,

Sunil Khushalani

The Stanley Research Program at Sheppard Pratt, Baltimore, MD

Search for more papers by this author

Armin Alaedini,

Armin Alaedini

Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, NY

Search for more papers by this author

Robert Yolken,

Robert Yolken

The Stanley Neurovirology Laboratory, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, MD, USA

Search for more papers by this author

Faith Dickerson,

Faith Dickerson

The Stanley Research Program at Sheppard Pratt, Baltimore, MD

Search for more papers by this author

Cassie Stallings,

Cassie Stallings

The Stanley Research Program at Sheppard Pratt, Baltimore, MD

Search for more papers by this author

Andrea Origoni,

Andrea Origoni

The Stanley Research Program at Sheppard Pratt, Baltimore, MD

Search for more papers by this author

Crystal Vaughan,

Crystal Vaughan

The Stanley Research Program at Sheppard Pratt, Baltimore, MD

Search for more papers by this author

Sunil Khushalani,

Sunil Khushalani

The Stanley Research Program at Sheppard Pratt, Baltimore, MD

Search for more papers by this author

Armin Alaedini,

Armin Alaedini

Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, NY

Search for more papers by this author

Robert Yolken,

Robert Yolken

The Stanley Neurovirology Laboratory, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, MD, USA

Search for more papers by this author

First published: 14 February 2011

https://doi.org/10.1111/j.1399-5618.2011.00894.x

Citations: 50

Corresponding author:
Faith Dickerson, Ph.D., M.P.H.
Sheppard Pratt
6501 North Charles Street
Baltimore, MD 21204, USA
Fax: 410-938-4364
E-mail: [email protected]

RY is a member of the Stanley Medical Research Institute Board of Directors and Scientific Advisory Board. The terms of this arrangement are being managed by the Johns Hopkins University in accordance with its conflict of interest policies. FD, CS, AO, CV, SK, and AA have no biomedical financial interests or potential conflicts of interest to report.

Read the full text

About

PDF

Tools

Share a link

Email
Facebook
Twitter
LinkedIn
Reddit
Wechat

Abstract

Dickerson F, Stallings C, Origoni A, Vaughan C, Khushalani S, Alaedini A, Yolken R. Markers of gluten sensitivity and celiac disease in bipolar disorder.
Bipolar Disord 2011: 13: 52–58. © 2011 The Authors.
Journal compilation © 2011 John Wiley & Sons A/S.

Objectives: Increased immune sensitivity to dietary gluten proteins has been reported in schizophrenia but has not been studied in bipolar disorder. In this study, we examine the levels of antibody reactivity to gliadin, deamidated gliadin, and tissue transglutaminase (tTG) in individuals with bipolar disorder and compare these levels to those in individuals who do not have any history of psychiatric disorder.

Methods: The sample of 275 individuals included 102 with bipolar disorder and 173 controls without a psychiatric disorder. Immunoglobulin G (IgG) and immunoglobulin A (IgA) antibodies to gliadin and tTG and IgG antibodies to deamidated gliadin were measured by enzyme immunoassay. Participants’ levels of antibodies to deamidated gliadin and tTG were classified based on the cutoffs for positivity that are predictive of celiac disease. Quantitative levels of antibodies were compared between groups employing regression models which were controlled for demographic variables.

Results: Individuals with bipolar disorder had increased levels of IgG antibodies to gliadin compared with controls in multivariate analyses. We also found evidence of increased levels of antibodies to deamidated gliadin in the bipolar disorder population. The levels of IgA class antigliadin antibodies and antibodies to tTG did not differ significantly between groups. There was also not a significant difference between groups in the number of persons who were classified as having levels of antibodies to deamidated gliadin or tTG that are predictive of celiac disease.

Conclusions: Individuals with bipolar disorder have increased levels of IgG antibodies to gliadin. However, such antibody increase is not accompanied by an elevation in IgA antibodies to gliadin or the celiac disease-associated antibodies against deamidated gliadin and tTG. These results warrant further detailed examination of the molecular specificity and pattern of reactivity of the antibody response to gluten antigens in bipolar disorder.

References

1 O’Brien SM, Scully P, Scott LV, Dinan TG. Cytokine profiles in bipolar affective disorder: focus on acutely ill patients. J Affect Disord 2006; 90: 263–267.
10.1016/j.jad.2005.11.015
CASPubMedWeb of Science®Google Scholar
2 Liu HC, Yang YY, Chou YM, Chen KP, Shen WW, Leu SJ. Immunologic variables in acute mania of bipolar disorder. Neuroimmunol 2004; 150: 116–122.
10.1016/j.jneuroim.2004.01.006
CASPubMedWeb of Science®Google Scholar
3 Dickerson F, Stallings C, Origoni A et al. Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episode schizophrenia. Biol Psychiatry 2010; 68: 101–104.
10.1016/j.biopsych.2010.03.021
CASWeb of Science®Google Scholar
4 Dohan FC, Martin L, Grasberger JC, Boehme D, Cottrell JC. Antibodies to wheat gliadin in blood of psychiatric patients: possible role of emotional factors. Biol Psychiatry 1972; 5: 127–137.

CASPubMedWeb of Science®Google Scholar
5 Reichelt KL, Landmark J. Specific IgA antibody increases in schizophrenia. Biol Psychiatry 1995; 37: 410–413.
10.1016/0006-3223(94)00176-4
CASPubMedWeb of Science®Google Scholar
6 Cascella NG, Kryszak D, Bhatti B et al. Prevalence of celiac disease and gluten sensitivity in the United States Clinical Antipsychotic Trials of Intervention Effectiveness Study population. Schizophr Bull 2011; 37: 94–100.
10.1093/schbul/sbp055
PubMedWeb of Science®Google Scholar
7 Sapone A, Lammers KM, Mazzarella G et al. Differential mucosal IL-17 expression in two gliadin-induced disorders: gluten sensitivity and the autoimmune enteropathy celiac disease. Int Arch Allergy Immunol 2010; 152: 75–80.
10.1159/000260087
CASPubMedWeb of Science®Google Scholar
8 Mothes T. Deamidated gliadin peptides as targets for celiac disease-specific antibodies. Adv Clin Chem 2007; 44: 35–63.
10.1016/S0065-2423(07)44002-1
CASPubMedWeb of Science®Google Scholar
9 Dohan FC. Coeliac disease and schizophrenia. Lancet 1970; 1: 897–898.
10.1016/S0140-6736(70)91729-0
CASPubMedWeb of Science®Google Scholar
10 Dohan FC. More on celiac disease as a model for schizophrenia. Biol Psychiatry 1983; 18: 561–564.

PubMedWeb of Science®Google Scholar
11 Eaton W, Mortensen PB, Agerbo E, Byrne M, Mors O, Ewald H. Coeliac disease and schizophrenia: population based case control study with linkage of Danish national registers. BMJ 2004; 328: 438–439.
10.1136/bmj.328.7437.438
PubMedWeb of Science®Google Scholar
12 West J, Logan RF, Hubbard RB, Card TR. Risk of schizophrenia in people with coeliac disease, ulcerative colitis and Crohn’s disease: a general population-based study. Aliment Pharmacol Ther 2006; 23: 71–74.
10.1111/j.1365-2036.2006.02720.x
CASPubMedWeb of Science®Google Scholar
13 Ludvigsson JF, Osby U, Ekbom A, Montgomery SM. Coeliac disease and risk of schizophrenia and other psychosis: a general population cohort study. Scand J Gastroenterol 2007; 42: 179–185.
10.1080/00365520600863472
PubMedWeb of Science®Google Scholar
14 Peleg R, Ben-Zion ZI, Peleg A et al. “Bread madness” revisited: screening for specific celiac antibodies among schizophrenia patients. Eur Psychiatry 2004; 19: 311–314.
10.1016/j.eurpsy.2004.06.003
PubMedWeb of Science®Google Scholar
15 Samaroo D, Dickerson F, Kasarda DD et al. Novel immune response to gluten in individuals with schizophrenia. Schizophr Res 2010; 118: 248–255.
10.1016/j.schres.2009.08.009
PubMedWeb of Science®Google Scholar
16 First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition. (SCID-I/P). New York: Biometrics Research, New York State Psychiatric Institute, 1998.

Google Scholar
17 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Press, 1994.

PubMedGoogle Scholar
18 First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders–Non-patient Edition. (SCID-I/NP). New York: Biometrics Research, New York State Psychiatric Institute, 1998.

Google Scholar
19 Reinton N, Helgheim A, Shegarfi H, Moghaddam A. A one-step real-time PCR assay for detection of DQA1*05, DQB1*02 and DQB1*0302 to aid diagnosis of celiac disease. J Immunol Methods 2006; 316: 125–132.
10.1016/j.jim.2006.08.008
CASPubMedWeb of Science®Google Scholar
20 Randolph C, Tierney MC, Mohr E, Chase TN. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol 1998; 20: 310–319.
10.1076/jcen.20.3.310.823
CASPubMedWeb of Science®Google Scholar
21 Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261–276.
10.1093/schbul/13.2.261
CASPubMedWeb of Science®Google Scholar
22 Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429–435.
10.1192/bjp.133.5.429
CASPubMedWeb of Science®Google Scholar
23 Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6: 278–296.
10.1111/j.2044-8260.1967.tb00530.x
CASPubMedWeb of Science®Google Scholar
24 Briani C, Samaroo D, Alaedini A. Celiac disease: from gluten to autoimmunity. Autoimmun Rev 2008; 7: 644–650.
10.1016/j.autrev.2008.05.006
CASPubMedWeb of Science®Google Scholar
25 Alaedini A, Green PH. Narrative review: celiac disease: understanding a complex autoimmune disorder. Ann Intern Med 2005; 142: 289–298.
10.7326/0003-4819-142-4-200502150-00011
CASPubMedWeb of Science®Google Scholar
26 Volta U, Granito A, Parisi C et al. Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis. J Clin Gastroenterol 2010; 44: 186–190.
10.1097/MCG.0b013e3181c378f6
PubMedWeb of Science®Google Scholar
27 Aleanzi M, Demonte AM, Esper C, Garcilazo S, Waggener M. Celiac disease: antibody recognition against native and selectively deamidated gliadin peptides. Clin Chem 2001; 47: 2023–2028.
10.1093/clinchem/47.11.2023
CASPubMedWeb of Science®Google Scholar
28 Parizade M, Bujanover Y, Weiss B, Nachmias V, Shainberg B. Performance of serology assays for diagnosing celiac disease in a clinical setting. Clin Vaccine Immunol 2009; 16: 1576–1582.
10.1128/CVI.00205-09
CASPubMedWeb of Science®Google Scholar
29 Severance E, Dickerson FB, Yolken RH. Complex immune system responses to bovine casein in people with psychiatric disorders. Presented at the 17^th Annual Meeting of the Psychoneuroimmunology Research Society, Dublin, 2–5 June 2010.

Google Scholar
30 Severance EG, Dickerson FB, Halling M et al. Subunit and whole molecule specificity of the anti-bovine casein immune response in recent onset psychosis and schizophrenia. Schizophr Res 2010; 118: 240–247.
10.1016/j.schres.2009.12.030
PubMedWeb of Science®Google Scholar

Citing Literature

Volume13, Issue1

February 2011

Pages 52-58

Markers of gluten sensitivity and celiac disease in bipolar disorder

Abstract

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Markers of gluten sensitivity and celiac disease in bipolar disorder

Abstract

References

Citing Literature

References

Related

Information